Skip to main content

Table 5 Changes in pharmacological treatment rates over the study period

From: Improving organisational systems for diabetes care in Australian Indigenous communities

Treatment Baseline Year 1 Year 2 Risk Ratios (95% CI) Year 1 vs baseline Risk Ratios (95% CI) Year 2 vs baseline
Any insulin use 10% (29/295) 11% (29/253) 10% (24/252) 1.17 (0.96, 1.40) 0.97 (0.79, 1.19)
Oral hypoglycaemic agents only 69% (203/295) 72% (181/253) 71% (180/252) 1.05 (0.83, 1.21) 1.08 (0.92, 1.20)
Hypertension on treatment 78% (112/143) 89% (111/125) 75% (119/159) 1.16 (1.04, 1.22) 0.96 (0.79, 1.09)
Albuminuria on ACE inhibitor 85% (129/151) 85% (124/146) 72% (114/158) 1.02 (0.86, 1.11) 0.87 (0.69, 1.00)
Hyperlipidemia on statin 71% (99/140) 83% (128/154) 67% (98/146) 1.34 (1.18, 1.39) 0.93 (0.75, 1.09)
Coronary heart disease/stroke on aspirin 56% (32/57) 60% (30/50) 70% (30/43) 1.00 (0.46, 1.47) 1.30 (0.85, 1.59)
Aspirin use among diabetes patients without cardiovascular events but with one or more other cardiovascular risk factors* 31% (53/173) 55% (91/165) 55% (101/184) 2.90 (2.11, 3.15) 2.21 (1.67, 2.62)
  1. * Other cardiovascular risks refer to hypertension, hyperlipidemia and smoking.
  2. † Risk ratios significant at 0.05 level are shown in bold.